-
Patient-led group launches network of clinics to improve LGMD care
Patient-led nonprofit The Speak Foundation has announced the launch of the LGMD Centers of Excellence,
-
Clinical Research Alert: Phase 3 Study of Omaveloxolone in Children and Teenagers with Friedreich Ataxia (FA)
Researchers at Biogen are seeking pediatric FA patients to participate in a phase 3 clinical








